Italy Marketing Director – Oncology Launch Leader

About Acadia PharmaceuticalsSe sta pensando di inviare una candidatura, si ricordi di premere il pulsante apposito dopo aver letto l'intera descrizione.Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio...

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-added cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target...

About Acadia PharmaceuticalsAcadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the...

Compensation: EUR 114 - EUR 216.5 - yearlyÈ pronto/a a candidarsi? Si assicuri di aver compreso tutte le responsabilità e i compiti associati a questo ruolo prima di procedere.Company DescriptionAbbVie's mission is to discover and provide innovative therapies and solutions that address today's serious diseases and meet the medical challenges of tomorrow....

Compensation: EUR 114 - EUR 216.5 - yearlyCompany DescriptionAbbVie's mission is to discover and provide innovative therapies and solutions that address today's serious diseases and meet the medical challenges of tomorrow. We strive to make a remarkable impact on patients' lives in several key therapeutic areas: immunology, ophthalmology, oncology,...

About Acadia PharmaceuticalsAcadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the...

Evolus (Nasdaq: EOLS) is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. Evolus International is the fastest-growing business unit. Today we operate in more than 7 countries, and over the next five years we plan to expand into more than 13 countries. That growth only works if we build a Digital...

Evolus (Nasdaq: EOLS) is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. Evolus International is the fastest-growing business unit. Today we operate in more than 7 countries, and over the next five years we plan to expand into more than 13 countries. That growth only works if we build a Digital...

Evolus (Nasdaq: EOLS) is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. Evolus International is the fastest-growing business unit. Today we operate in more than 7 countries, and over the next five years we plan to expand into more than 13 countries. That growth only works if we build a Digital...